Separation of hemolytic substances from anticancer preparations of hemolytic streptococci.
Preparations 60F and 50F isolated from the cell-free extract of anticancer hemolytic streptococci possessed not only anticancer activity but hemolytic activity. Thus, the experiment to separate hemolytic substances from 60F and 50F were carried out. Three kinds of fractions were obtained from 60F or 50F by dissolving them in ammonium sulfate solutions of various concentrations. These fractions were named 60F-I, 60F-II and 60F-III, and 50F-I, 50F-II and 50F-III, respectively. 60F-I and 50F-I possessed neither anticancer activity nor hemolytic activity. 60F-II and 50F-II possessed only anticancer activity, and 60F-III and 50F-III possessed only hemolytic activity. Thus, hemolytic substances were separated from 60F and 50F, and it was demonstrated that the anticancer activity of hemolytic streptococci was not due to their hemolysins or hemolytic activity.
D000645:Ammonium Sulfate / Q000494:pharmacology; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D001688:Biological Products / Q000032:analysis*; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy*; D006460:Hemolysin Proteins / Q000032:analysis / Q000302:isolation & purification; D007274:Injections, Intraperitoneal; D008297:Male; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy; D010844:Picibanil / Q000008:administration & dosage / Q000032:analysis* / Q000145:classification / Q000302:isolation & purification / Q000494:pharmacology; D013297:Streptococcus pyogenes / Q000032:analysis*
D000970:Antineoplastic Agents; D001688:Biological Products; D006460:Hemolysin Proteins; D010844:Picibanil; D000645:Ammonium Sulfate